SG Americas Securities LLC Sells 13,032 Shares of Masimo Co. (MASI)

SG Americas Securities LLC trimmed its holdings in shares of Masimo Co. (NASDAQ:MASI) by 71.4% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,224 shares of the medical equipment provider’s stock after selling 13,032 shares during the period. SG Americas Securities LLC’s holdings in Masimo were worth $452,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Great West Life Assurance Co. Can boosted its position in Masimo by 0.3% during the second quarter. Great West Life Assurance Co. Can now owns 26,913 shares of the medical equipment provider’s stock worth $2,452,000 after acquiring an additional 88 shares during the last quarter. Daiwa Securities Group Inc. acquired a new position in shares of Masimo in the 2nd quarter valued at $219,000. World Asset Management Inc boosted its holdings in shares of Masimo by 4.6% in the 2nd quarter. World Asset Management Inc now owns 2,853 shares of the medical equipment provider’s stock valued at $260,000 after purchasing an additional 126 shares during the last quarter. Cigna Investments Inc. New acquired a new position in shares of Masimo in the 2nd quarter valued at $332,000. Finally, Arizona State Retirement System boosted its holdings in shares of Masimo by 2.7% in the 2nd quarter. Arizona State Retirement System now owns 19,200 shares of the medical equipment provider’s stock valued at $1,751,000 after purchasing an additional 500 shares during the last quarter. 83.74% of the stock is owned by institutional investors and hedge funds.

In other news, Director Steven Barker sold 10,000 shares of the firm’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $90.00, for a total value of $900,000.00. Following the transaction, the director now owns 73,249 shares of the company’s stock, valued at approximately $6,592,410. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Yongsam Lee sold 5,900 shares of the firm’s stock in a transaction on Friday, December 1st. The shares were sold at an average price of $88.31, for a total transaction of $521,029.00. Following the completion of the transaction, the executive vice president now directly owns 70,800 shares in the company, valued at approximately $6,252,348. The disclosure for this sale can be found here. In the last three months, insiders sold 53,074 shares of company stock worth $4,737,245. Insiders own 13.10% of the company’s stock.

MASI has been the topic of a number of research analyst reports. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price target on shares of Masimo in a report on Friday, November 3rd. Zacks Investment Research upgraded shares of Masimo from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a report on Thursday, November 2nd. Finally, BidaskClub lowered shares of Masimo from a “hold” rating to a “sell” rating in a report on Thursday, December 7th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus price target of $97.17.

Masimo Co. (MASI) opened at $85.11 on Wednesday. Masimo Co. has a 1-year low of $64.29 and a 1-year high of $104.71. The firm has a market cap of $4,417.88, a price-to-earnings ratio of 32.76, a price-to-earnings-growth ratio of 2.88 and a beta of 0.72.

Masimo (NASDAQ:MASI) last issued its earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 EPS for the quarter, beating the Zacks’ consensus estimate of $0.53 by $0.17. Masimo had a net margin of 45.83% and a return on equity of 22.17%. The business had revenue of $193.69 million for the quarter, compared to the consensus estimate of $189.01 million. During the same quarter last year, the firm posted $0.52 EPS. The business’s revenue for the quarter was up 15.6% compared to the same quarter last year. research analysts expect that Masimo Co. will post 2.95 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “SG Americas Securities LLC Sells 13,032 Shares of Masimo Co. (MASI)” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another site, it was illegally stolen and reposted in violation of international copyright and trademark legislation. The original version of this story can be viewed at https://www.dispatchtribunal.com/2017/12/13/sg-americas-securities-llc-sells-13032-shares-of-masimo-co-masi.html.

Masimo Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply